Henry Schein, Inc. (NASDAQ:HSIC) Shares Purchased by UniSuper Management Pty Ltd

UniSuper Management Pty Ltd raised its position in Henry Schein, Inc. (NASDAQ:HSIC) by 10.3% during the fourth quarter, Holdings Channel.com reports. The firm owned 24,957 shares of the company’s stock after buying an additional 2,338 shares during the period. UniSuper Management Pty Ltd’s holdings in Henry Schein were worth $1,727,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of HSIC. Cerity Partners LLC boosted its position in Henry Schein by 12.3% during the third quarter. Cerity Partners LLC now owns 26,339 shares of the company’s stock worth $1,920,000 after acquiring an additional 2,894 shares during the last quarter. FMR LLC boosted its holdings in shares of Henry Schein by 7.8% during the third quarter. FMR LLC now owns 3,280,890 shares of the company’s stock worth $239,177,000 after purchasing an additional 237,888 shares during the last quarter. BNP Paribas Financial Markets grew its position in shares of Henry Schein by 5.4% in the third quarter. BNP Paribas Financial Markets now owns 184,482 shares of the company’s stock valued at $13,449,000 after purchasing an additional 9,465 shares during the period. Glenmede Trust Co. NA increased its stake in Henry Schein by 13.3% in the third quarter. Glenmede Trust Co. NA now owns 11,257 shares of the company’s stock valued at $821,000 after purchasing an additional 1,324 shares during the last quarter. Finally, Public Sector Pension Investment Board lifted its position in Henry Schein by 8.1% during the third quarter. Public Sector Pension Investment Board now owns 5,336 shares of the company’s stock worth $389,000 after buying an additional 400 shares during the period. 96.62% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

HSIC has been the subject of several recent analyst reports. Wells Fargo & Company initiated coverage on Henry Schein in a report on Friday, February 14th. They issued an “equal weight” rating and a $80.00 price target for the company. Mizuho started coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price target for the company. Barrington Research reiterated an “outperform” rating and issued a $90.00 price target on shares of Henry Schein in a report on Wednesday, February 26th. Jefferies Financial Group upped their price objective on Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a report on Thursday, January 23rd. Finally, Bank of America upgraded Henry Schein from an “underperform” rating to a “buy” rating and lifted their target price for the company from $69.00 to $84.00 in a report on Monday, January 6th. Six investment analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $81.10.

Henry Schein Trading Down 1.1 %

Shares of HSIC opened at $68.62 on Monday. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. Henry Schein, Inc. has a 12 month low of $63.67 and a 12 month high of $82.49. The stock has a market cap of $8.52 billion, a PE ratio of 28.24, a P/E/G ratio of 2.13 and a beta of 0.90. The stock’s 50-day moving average is $74.62 and its two-hundred day moving average is $72.68.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). The company had revenue of $3.19 billion during the quarter, compared to analysts’ expectations of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm’s revenue was up 5.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.66 EPS. Equities analysts forecast that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Insider Activity at Henry Schein

In other news, Director Philip A. Laskawy sold 2,604 shares of Henry Schein stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total transaction of $184,988.16. Following the sale, the director now directly owns 24,805 shares of the company’s stock, valued at approximately $1,762,147.20. The trade was a 9.50 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Bradford C. Connett sold 4,036 shares of the business’s stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the transaction, the chief executive officer now owns 62,688 shares in the company, valued at approximately $4,460,251.20. This trade represents a 6.05 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.14% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.